Literature DB >> 23835792

Monitoring the nociception level: a multi-parameter approach.

Nir Ben-Israel1, Mark Kliger, Galit Zuckerman, Yeshayahu Katz, Ruth Edry.   

Abstract

The aim of the present study was to develop and validate an objective index for nociception level (NoL) of patients under general anesthesia, based on a combination of multiple physiological parameters. Twenty-five patients scheduled for elective surgery were enrolled. For clinical reference of NoL, the combined index of stimulus and analgesia was defined as a composite of the surgical stimulus level and a scaled effect-site concentration of opioid. The physiological parameters heart rate, heart rate variability (0.15-0.4 Hz band power), plethysmograph wave amplitude, skin conductance level, number of skin conductance fluctuations, and their time derivatives, were extracted. Two techniques to incorporate these parameters into a single index representing the NoL have been proposed: NoLlinear, based on an ordinary linear regression, and NoLnon-linear, based on a non-linear Random Forest regression. NoLlinear and NoLnon-linear significantly increased after moderate to severe noxious stimuli (Wilcoxon rank test, p < 0.01), while the individual parameters only partially responded. Receiver operating curve analysis showed that NoL index based on both techniques better discriminated noxious and non-noxious surgical events [area under curve (AUC) = 0.97] compared with individual parameters (AUC = 0.56-0.74). NoLnon-linear better ranked the level of nociception compared with NoLlinear (R = 0.88 vs. 0.77, p < 0.01). These results demonstrate the superiority of multi-parametric approach over any individual parameter in the evaluation of nociceptive response. In addition, advanced non-linear technique may have an advantage over ordinary linear regression for computing NoL index. Further research will define the usability of the NoL index as a clinical tool to assess the level of nociception during general anesthesia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23835792     DOI: 10.1007/s10877-013-9487-9

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  38 in total

1.  Palmar skin conductance compared to a developed stress score and to noxious and awakening stimuli on patients in anaesthesia.

Authors:  H Storm; M Shafiei; K Myre; J Raeder
Journal:  Acta Anaesthesiol Scand       Date:  2005-07       Impact factor: 2.105

Review 2.  The Kyoto protocol of IASP Basic Pain Terminology.

Authors:  John D Loeser; Rolf-Detlef Treede
Journal:  Pain       Date:  2008-06-25       Impact factor: 6.961

3.  Monitoring of skin conductance to assess postoperative pain intensity.

Authors:  T Ledowski; J Bromilow; M J Paech; H Storm; R Hacking; S A Schug
Journal:  Br J Anaesth       Date:  2006-10-22       Impact factor: 9.166

4.  Reduction of isoflurane minimal alveolar concentration by remifentanil.

Authors:  E Lang; A Kapila; D Shlugman; J F Hoke; P S Sebel; P S Glass
Journal:  Anesthesiology       Date:  1996-10       Impact factor: 7.892

5.  Autonomic measures and behavioral indices of pain sensitivity.

Authors:  John Dowling
Journal:  Pain       Date:  1983-06       Impact factor: 6.961

6.  Isoflurane produces marked and nonlinear decreases in the vasoconstriction and shivering thresholds.

Authors:  J Xiong; A Kurz; D I Sessler; O Plattner; R Christensen; M Dechert; T Ikeda
Journal:  Anesthesiology       Date:  1996-08       Impact factor: 7.892

7.  Variations of the analgesia nociception index during general anaesthesia for laparoscopic abdominal surgery.

Authors:  M Jeanne; C Clément; J De Jonckheere; R Logier; B Tavernier
Journal:  J Clin Monit Comput       Date:  2012-03-28       Impact factor: 2.502

8.  Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care.

Authors:  M F Mascia; M Koch; J J Medicis
Journal:  Crit Care Med       Date:  2000-07       Impact factor: 7.598

9.  Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

Authors:  C F Minto; T W Schnider; T D Egan; E Youngs; H J Lemmens; P L Gambus; V Billard; J F Hoke; K H Moore; D J Hermann; K T Muir; J W Mandema; S L Shafer
Journal:  Anesthesiology       Date:  1997-01       Impact factor: 7.892

10.  An evaluation of remifentanil propofol response surfaces for loss of responsiveness, loss of response to surrogates of painful stimuli and laryngoscopy in patients undergoing elective surgery.

Authors:  Ken B Johnson; Noah D Syroid; Dhanesh K Gupta; Sandeep C Manyam; Talmage D Egan; Jeremy Huntington; Julia L White; Diane Tyler; Dwayne R Westenskow
Journal:  Anesth Analg       Date:  2008-02       Impact factor: 5.108

View more
  26 in total

1.  Comparison of the qCON and qNOX indices for the assessment of unconsciousness level and noxious stimulation response during surgery.

Authors:  Umberto Melia; Eva Gabarron; Mercé Agustí; Nuria Souto; Patricia Pineda; Joan Fontanet; Montserrat Vallverdu; Erik Weber Jensen; Pedro Gambus
Journal:  J Clin Monit Comput       Date:  2016-10-20       Impact factor: 2.502

Review 2.  Physiological Signal Processing for Individualized Anti-nociception Management During General Anesthesia: a Review.

Authors:  J De Jonckheere; V Bonhomme; M Jeanne; E Boselli; M Gruenewald; R Logier; P Richebé
Journal:  Yearb Med Inform       Date:  2015-08-13

Review 3.  The quantification and monitoring of intraoperative nociception levels in thoracic surgery: a review.

Authors:  Ismael Ghanty; Stefan Schraag
Journal:  J Thorac Dis       Date:  2019-09       Impact factor: 2.895

4.  A classification algorithm to predict chronic pain using both regression and machine learning - A stepwise approach.

Authors:  Pao-Feng Tsai; Chih-Hsuan Wang; Yang Zhou; Jiaxiang Ren; Alisha Jones; Sarah O Watts; Chiahung Chou; Wei-Shinn Ku
Journal:  Appl Nurs Res       Date:  2021-09-28       Impact factor: 2.257

5.  Prediction of acute postoperative pain based on intraoperative nociception level (NOL) index values: the impact of machine learning-based analysis.

Authors:  Louis Morisson; Mathieu Nadeau-Vallée; Fabien Espitalier; Pascal Laferrière-Langlois; Moulay Idrissi; Nadia Lahrichi; Céline Gélinas; Olivier Verdonck; Philippe Richebé
Journal:  J Clin Monit Comput       Date:  2022-08-04       Impact factor: 1.977

Review 6.  Description of the validity of the Analgesia Nociception Index (ANI) and Nociception Level Index (NOL) for nociception assessment in anesthetized patients undergoing surgery: a systematized review.

Authors:  T Shiva Shahiri; Philippe Richebé; Melissa Richard-Lalonde; Céline Gélinas
Journal:  J Clin Monit Comput       Date:  2021-11-16       Impact factor: 1.977

7.  A beat-by-beat cardiovascular index, CARDEAN, to titrate opioid administration in the setting of orthopaedic surgery: a prospective randomized trial.

Authors:  Pierre-François Wey; Damien Loheas; Antoine Lamblin; Benjamin Riche; Muriel Rabilloud; Jacques Escarment; Marc Puidupin; Luc Quintin; Jean-Yves Martinez; Andrei Cividjian
Journal:  J Clin Monit Comput       Date:  2020-10-06       Impact factor: 2.502

8.  Pain Recognition With Electrocardiographic Features in Postoperative Patients: Method Validation Study.

Authors:  Emad Kasaeyan Naeini; Ajan Subramanian; Michael-David Calderon; Kai Zheng; Nikil Dutt; Pasi Liljeberg; Sanna Salantera; Ariana M Nelson; Amir M Rahmani
Journal:  J Med Internet Res       Date:  2021-05-28       Impact factor: 5.428

9.  Clinical characterization of dysautonomia in long COVID-19 patients.

Authors:  Nicolas Barizien; Morgan Le Guen; Stéphanie Russel; Pauline Touche; Florent Huang; Alexandre Vallée
Journal:  Sci Rep       Date:  2021-07-07       Impact factor: 4.379

10.  Development of a Hemodynamic Model Using Routine Monitoring Parameters for Nociceptive Responses Evaluation During Surgery Under General Anesthesia.

Authors:  Munetaka Hirose; Yoshiko Kobayashi; Shiro Nakamoto; Ryusuke Ueki; Nobutaka Kariya; Tsuneo Tatara
Journal:  Med Sci Monit       Date:  2018-05-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.